focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 488.00
Bid: 490.00
Ask: 495.00
Change: 12.00 (2.52%)
Spread: 5.00 (1.02%)
Open: 478.00
High: 491.00
Low: 474.00
Prev. Close: 476.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

7 Jan 2015 07:00

RNS Number : 4767B
Zotefoams PLC
07 January 2015
 



Zotefoams plc

("Zotefoams" or "the Company")

 

Trading Update

 

7 January 2015 - Zotefoams, a world leader in cellular material technology, today provides a trading update following the Company's financial year end on 31 December 2014.

 

For the year ended 31 December 2014 Zotefoams will report sales growth in all major areas of the business with overall sales approximately 10%1 ahead of 2013 in reporting currency which is equivalent to growth of approximately 15% in constant currency.

 

In constant currency, High-Performance Products sales grew by approximately 60% while sales in MuCell Extrusion, our technology licensing business, increased by approximately 40%. Polyolefin sales volumes increased by 9% in the year, although the fourth quarter was impacted by delayed shipments. While it is normal to have some carry-over of planned shipments from month to month, the level was approximately £1.5m higher than we expected. This shortfall, which will despatch in early 2015, will result in a lower level of profitability from Polyolefin foams than previously anticipated. These delays were a result of unanticipated administrative bottlenecks following the implementation of our new ERP IT system. While we are confident that all substantive issues have now been resolved there was insufficient time to ship all orders before year end. We enter 2015 with a revenue backlog from Polyolefin foams as well as a strong order book for the start of the new year.

 

The Board expects to report an earnings outcome slightly below the lower end of market expectations when preliminary results are announced on Tuesday 17 March, 2015. With 2014 seeing strong operating profit2 growth and sales momentum into 2015, the Board remains confident of continued progress in the future.

 

 

Enquiries:

Zotefoams plc

0208-664-1600

David Stirling, Managing Director

Clifford Hurst, Finance Director

FTI Consulting

0203-727-1000

Victoria Foster Mitchell, Simon Conway

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

 

ZOTEK® is a registered trademark of Zotefoams plc. MuCell® is a registered trademark of Trexel Inc. T-Tubes® is a registered trademark of UFP Technologies Inc.

 

 

1 Sales made by joint ventures as well as those made by Zotefoams plc and its subsidiaries.

2 Before exceptional items

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMGGMFVMGKZZ
Date   Source Headline
12th Sep 20184:14 pmRNSDirector/PDMR Shareholding
22nd Aug 20184:34 pmRNSHolding(s) in Company
22nd Aug 20182:05 pmRNSHolding(s) in Company
15th Aug 201811:59 amRNSHolding(s) in Company
15th Aug 201811:53 amRNSDirector/PDMR Shareholding
7th Aug 20187:00 amRNSInterim Results
25th Jul 20182:47 pmRNSHolding(s) in Company
25th Jul 20182:47 pmRNSHolding(s) in Company
16th Jul 20189:12 amRNSHolding(s) in Company
12th Jul 201811:47 amRNSDirector/PDMR Shareholding
9th Jul 20187:00 amRNSNotice of Results
12th Jun 20184:45 pmRNSDirector/PDMR Shareholding
4th Jun 20185:50 pmRNSDirector/PDMR Shareholding
4th Jun 20189:30 amRNSDirector Declaration
1st Jun 20184:39 pmRNSTotal Voting Rights
1st Jun 20184:37 pmRNSHolding(s) in Company
31st May 201811:57 amRNSDirector/PDMR Shareholding
29th May 20185:34 pmRNSDirector/PDMR Shareholding
22nd May 201812:28 pmRNSHolding(s) in Company
21st May 20184:04 pmRNSHolding(s) in Company
21st May 20187:00 amRNSDirector/PDMR Shareholding
17th May 20184:08 pmRNSHolding(s) in Company
16th May 20181:35 pmRNSResult of AGM
16th May 20187:00 amRNSCompletion of placing
15th May 20184:39 pmRNSProposed placing of shares in Zotefoams plc
14th May 20183:09 pmRNSDirector/PDMR Shareholding
13th Apr 20189:43 amRNSDirector/PDMR Shareholding
12th Apr 20182:27 pmRNS2017 Annual Report and Notice of the 2018 AGM
13th Mar 20185:30 pmRNSDirector/PDMR Shareholding
13th Mar 20187:00 amRNSFinal Results
9th Mar 20187:00 amRNSHolding(s) in Company
22nd Feb 20184:54 pmRNSHolding(s) in Company
22nd Feb 20184:48 pmRNSHolding(s) in Company
13th Feb 20187:00 amRNSDirector/PDMR Shareholding
16th Jan 20184:55 pmRNSHolding(s) in Company
12th Jan 201811:37 amRNSDirector/PDMR Shareholding
22nd Dec 201712:27 pmRNSDirector/PDMR Shareholding
21st Dec 20177:00 amRNSDirectorate Change
18th Dec 20174:10 pmRNSHolding(s) in Company
14th Dec 20177:00 amRNS£12 million investment planned at Croydon facility
13th Dec 20177:00 amRNSDirector/PDMR Shareholding
13th Dec 20177:00 amRNSStrategic Partnership with Nike
15th Nov 20177:00 amRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSThird Quarter Trading Update
17th Oct 20171:08 pmRNSDirector/PDMR Shareholding
10th Oct 20177:00 amRNSDirector/PDMR Shareholding
28th Sep 20177:00 amRNSHolding(s) in Company
13th Sep 20177:00 amRNSDirector/PDMR Shareholding
16th Aug 20177:00 amRNSHolding(s) in Company
11th Aug 20175:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.